Improving Patient Care Through Technology
Kedrion is a plasma products company supporting the development of our dehydrated plasma product Resusix Kedrion’s solvent detergent treated plasma product serves as the precursor to Resusix
Beeken Biomedical is a medical device company dedicated to the advancement of bleeding control. Beeken licensed from Entegrion the initial innovation that formed the basis for their Hemafiber TechnologyTM used in their wound care products.
The U.S. Department of Defense has providing substantial funding for the Company’s Resusix and other technologies through a number of its technology offices and programs, with contract awards totaling in excess of $100 million, including government contract options.
Entegrion complies with applicable Federal Conflict of Interest rules.